Pharmidex attending the Global Business Accelerator visit to Switzerland
March 10, 2018

Pharmidex will be attending the Global Business Accelerator Program which is run by the Enterprise Europe Network and supported by Innovate UK.

The Enterprise Europe Network, supported by Innovate UK, are visiting Switzerland to focus on the pharmaceutical technology industry. The chosen companies will have the opportunity to meet pharmaceutical companies and key stakeholders based in Basel and attend ProcureCon Pharma in Zürich for the next three days


The Swiss pharmaceutical sector is a major employer with more than 40,000 people working directly for the industry. If the indirect work created through ancillary industries is included, as many as 172,000 jobs are related to the pharmaceutical industry. In addition, it accounts for up to a third of all Swiss exports, and the productivity of the industry is four times as high as that of the economy as a whole.


Three big clusters – the Lake Geneva area, the Basel region and Zürich-Zug-Lucerne – account for the lion’s share of the gross value added of the Swiss pharmaceutical industry and present many collabartive opputunities for UK companies. 


During the trip Pharmidex will also be attending ProcureCon Pharma, organised by Worldwide Business Research, will take place from 13 to 15 March 2018 in Zürich. Delegates will have the opportunity to join 200 senior procurement professionals from Merck, Astra Zeneca, Roche, Sanofi, Lonza and other world-leading pharmaceutical businesses over three days. 


We look forward to meeting you there.

February 24, 2026
Today we took a short pause from the science to enjoy some well-deserved donuts together in the office. At Pharmidex , we believe culture matters just as much as capability. Moments like this simple, informal, and inclusive are part of what keeps our team connected and motivated. As a preclinical CRO, we support over 400 clients each year from our UK laboratories, delivering high-quality in vivo and bioanalytical services to advance drug discovery programmes.  A small break. A strong team. Back to delivering great science. If we can support your next drug discovery project, do get in touch.
February 23, 2026
🧠 Did you know that Pharmidex offers specialist CNS preclinical services to accelerate neuroscience drug discovery? At Pharmidex, we provide expert in vivo and ex vivo neurochemistry and neurobehavioural capabilities to support the progression of CNS drug candidates across key readouts including PK, PD, target engagement and efficacy. Our CNS platform is designed to help you address the complex challenges of developing therapies for neurodegenerative and psychiatric disorders such as Alzheimer’s, Parkinson’s, schizophrenia and depression. From microdialysis and brain bioanalysis to blood–brain barrier assessment and sophisticated neurobehavioural models, we deliver actionable data to guide confident decision-making in your neuroscience programmes. Learn more about how Pharmidex can support your CNS research: 🔗 www.pharmidex.com/CNS
February 19, 2026
Science is serious… but Pancake Day is not. Yesterday we took a short pause from studies, data and reports to enjoy some well-earned pancakes together as a team. With Ramadan also beginning, we made sure there were plenty saved for colleagues breaking their fast later in the evening. At Pharmidex , we’re proud of the work we deliver, but we’re equally proud of the people behind it. Small moments like this remind us that strong teams are built not only in the lab, but around the table too. Thank you to everyone for your hard work and for making our culture what it is. 🙌
More Posts